Fast Market Research

"Molecular Insight Pharmaceuticals, Inc. - Product Pipeline Review - 2012" - New Market Report

Fast Market Research recommends "Molecular Insight Pharmaceuticals, Inc. - Product Pipeline Review - 2012" from Global Markets Direct, now available


Boston, MA -- (SBWIRE) -- 02/11/2013 -- Global Market Direct's pharmaceuticals report, "Molecular Insight Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Molecular Insight Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Molecular Insight Pharmaceuticals, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Molecular Insight Pharmaceuticals, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Molecular Insight Pharmaceuticals, Inc. - Brief Molecular Insight Pharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Molecular Insight Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Molecular Insight Pharmaceuticals, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Molecular Insight Pharmaceuticals, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get this Report

- Evaluate Molecular Insight Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Molecular Insight Pharmaceuticals, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Molecular Insight Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Molecular Insight Pharmaceuticals, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Molecular Insight Pharmaceuticals, Inc. and identify potential opportunities in those areas.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Molecular Insight Pharmaceuticals, Inc. - Product Pipeline Review - H2 2011
- Molecular Insight Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
- Pancreatic Cancer - Pipeline Review, H1 2012
- Albany Molecular Research, Inc. - Product Pipeline Review - 2012
- Alnylam Pharmaceuticals, Inc - Product Pipeline Review - 2012
- Gastrointestinal Tract Cancer - Pipeline Review, H2 2012
- Glenmark Pharmaceuticals Ltd. - Product Pipeline Review - 2012
- Molecular Insight Pharmaceuticals, Inc. (MIPI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- Age Related Macular Degeneration - Pipeline Review, H1 2012
- Takeda Pharmaceuticals International GmbH - Product Pipeline Review - 2012